Skip to content

Clinical trials

Phase 3 Sepsis trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sepsis Phase: Phase 3 Country / region: Italy Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20062
20082
20101
20122
20141
20151
20161
20182
20203

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Unknown status3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Università Vita-Salute San Raffaele2
Basilea Pharmaceutica1
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Eisai Inc.1
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico1
Fondazione IRCCS Policlinico San Matteo di Pavia1
Massimo Girardis1
Mundipharma Research Limited1
PENTA Foundation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sepsis17
Shock, Septic6
Systemic Inflammatory Response Syndrome3
Bacteremia2
Candidemia2
Candidiasis2
Candidiasis, Invasive2
Fungemia2
Invasive Fungal Infections2
Mycoses2

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.